Wirth LJ - Search Results

1

Outcome of patients with pulmonary carcinoid tumors receiving chemotherapy or chemoradiotherapy.

Wirth LJ, Carter MR, Jänne PA, Johnson BE. Wirth LJ, et al. Lung Cancer. 2004 May;44(2):213-20. doi: 10.1016/j.lungcan.2003.11.016. Lung Cancer. 2004. PMID: 15084386

2

Induction docetaxel and carboplatin followed by weekly docetaxel and carboplatin with concurrent radiotherapy, then surgery in stage III non-small cell lung cancer: a Phase I study.

Wirth LJ, Lucca J, Ostler P, Fidias P, Lynch C, Jänne PA, Herbst RS, Johnson BE, Sugarbaker DJ, Mathisen DJ, Lukanich JM, Choi NC, Berman SM, Skarin AT. Wirth LJ, et al. Clin Cancer Res. 2003 May;9(5):1698-704. Clin Cancer Res. 2003. PMID: 12738723 Clinical Trial.

3

Integration of chemotherapy in the curative treatment of locally advanced head and neck cancer.

Haddad RI, Wirth L, Posner MR. Haddad RI, et al. Expert Rev Anticancer Ther. 2003 Jun;3(3):331-8. doi: 10.1586/14737140.3.3.331. Expert Rev Anticancer Ther. 2003. PMID: 12820776 Review.

4

Induction chemotherapy in locally advanced squamous cell cancer of the head and neck: evolution of the sequential treatment approach.

Posner MR, Haddad RI, Wirth L, Norris CM, Goguen LA, Mahadevan A, Sullivan C, Tishler RB. Posner MR, et al. Semin Oncol. 2004 Dec;31(6):778-85. doi: 10.1053/j.seminoncol.2004.09.007. Semin Oncol. 2004. PMID: 15599855 Review.

5

Phase I study of gefitinib plus celecoxib in recurrent or metastatic squamous cell carcinoma of the head and neck.

Wirth LJ, Haddad RI, Lindeman NI, Zhao X, Lee JC, Joshi VA, Norris CM Jr, Posner MR. Wirth LJ, et al. J Clin Oncol. 2005 Oct 1;23(28):6976-81. doi: 10.1200/JCO.2005.02.4182. Epub 2005 Sep 19. J Clin Oncol. 2005. PMID: 16172459 Clinical Trial.

6

Chemoradiotherapy for adenoid cystic carcinoma: preliminary results of an organ sparing approach.

Haddad RI, Posner MR, Busse PM, Norris CM Jr, Goguen LA, Wirth LJ, Blinder R, Krane JF, Tishler RB. Haddad RI, et al. Among authors: wirth lj. Am J Clin Oncol. 2006 Apr;29(2):153-7. doi: 10.1097/01.coc.0000203756.36866.17. Am J Clin Oncol. 2006. PMID: 16601434

7

Concurrent weekly docetaxel and concomitant boost radiation therapy in the treatment of locally advanced squamous cell cancer of the head and neck.

Tishler RB, Posner MR, Norris CM Jr, Mahadevan A, Sullivan C, Goguen L, Wirth LJ, Costello R, Case M, Stowell S, Sammartino D, Busse PM, Haddad RI. Tishler RB, et al. Among authors: wirth lj. Int J Radiat Oncol Biol Phys. 2006 Jul 15;65(4):1036-44. doi: 10.1016/j.ijrobp.2006.02.010. Epub 2006 May 6. Int J Radiat Oncol Biol Phys. 2006. PMID: 16682134 Clinical Trial.

8

Examining the need for neck dissection in the era of chemoradiation therapy for advanced head and neck cancer.

Goguen LA, Posner MR, Tishler RB, Wirth LJ, Norris CM, Annino DJ, Sullivan CA, Li Y, Haddad RI. Goguen LA, et al. Among authors: wirth lj. Arch Otolaryngol Head Neck Surg. 2006 May;132(5):526-31. doi: 10.1001/archotol.132.5.526. Arch Otolaryngol Head Neck Surg. 2006. PMID: 16702569

9

Rate of pathologic complete responses to docetaxel, cisplatin, and fluorouracil induction chemotherapy in patients with squamous cell carcinoma of the head and neck.

Haddad R, Tishler R, Wirth L, Norris CM, Goguen L, Sullivan C, O'Donnell L, Li Y, Posner M. Haddad R, et al. Arch Otolaryngol Head Neck Surg. 2006 Jun;132(6):678-81. doi: 10.1001/archotol.132.6.678. Arch Otolaryngol Head Neck Surg. 2006. PMID: 16785415

10

Emerging drugs for head and neck cancer.

Haddad R, Wirth L, Posner M. Haddad R, et al. Expert Opin Emerg Drugs. 2006 Sep;11(3):461-7. doi: 10.1517/14728214.11.3.461. Expert Opin Emerg Drugs. 2006. PMID: 16939385 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

169 results

Search Page